Coral, a Canadian virtual clinic for midlife women, has raised an additional $4 million CAD (approximately $2.9 million USD) in an acceleration round just one year after launch, bringing total capital raised to over $8 million CAD (approximately $5.8 million USD). The round was led by Brightspark, Diagram, AQC Capital, Anges Quebec, and The51, with additional angel investors.
Coral integrates hormonal health, metabolic wellness, and weight management into a single clinical model for women navigating perimenopause, menopause, and midlife health – positioning itself as an alternative to what the company describes as fragmented, prescription-led telehealth services that treat symptoms in isolation.
The platform is reporting strong early outcomes data: 80% of members report significantly improved mental well-being and over 70% see an important reduction in perimenopause and menopause symptoms within 90 days.
“For too long, menopause has been addressed as a series of isolated symptoms rather than a complex metabolic and hormonal transition,” said CEO and co-founder Fiona Lake Waslander. “Unlike fragmented, prescription-led telehealth services for women that focus only on symptoms, Coral delivers an integrated clinical model designed to combine lifestyle and medical interventions, to help women optimize their health for the long term and truly thrive.”
“Coral is the Canadian brand defining this moment in women’s longevity,” said co-founder and executive chairwoman Anna Chif. “This investment will accelerate our growth and fulfill our mission to expand our comprehensive approach into a national standard that empowers women to thrive in their prime years. We aren’t just building a platform; we are closing the $37 billion Canadian economic gap and the 540,000 workdays lost annually by unmanaged women’s health.”
The funding will support national expansion across Canada, clinical team growth, and continued development of the platform’s AI capabilities. Coral was founded in 2024
